These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 16978460

  • 1. Influence of equinus treatments on the vertical displacement of the body's centre of mass in children with cerebral palsy.
    Massaad F, van den Hecke A, Renders A, Detrembleur C.
    Dev Med Child Neurol; 2006 Oct; 48(10):813-8. PubMed ID: 16978460
    [Abstract] [Full Text] [Related]

  • 2. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M, Allington N.
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
    [Abstract] [Full Text] [Related]

  • 3. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
    Yap R, Majnemer A, Benaroch T, Cantin MA.
    Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES, Rodrigues BM, Barroso M, Menezes CJ, Lucena RS, Nora DB, Melo A.
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.
    Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK.
    J Pediatr Orthop; 1998 Feb; 18(3):304-11. PubMed ID: 9600553
    [Abstract] [Full Text] [Related]

  • 6. Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint.
    Galli M, Crivellini M, Santambrogio GC, Fazzi E, Motta F.
    Funct Neurol; 2001 Feb; 16(4):317-23. PubMed ID: 11853322
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
    Koman LA, Mooney JF, Smith BP, Walker F, Leon JM.
    J Pediatr Orthop; 2000 Feb; 20(1):108-15. PubMed ID: 10641699
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
    Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
    [Abstract] [Full Text] [Related]

  • 9. Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin A in children with cerebral palsy.
    Zürcher AW, Molenaers G, Desloovere K, Fabry G.
    Acta Orthop Belg; 2001 Dec; 67(5):475-80. PubMed ID: 11822078
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of a dynamic foot pressure index to monitor the effects of treatment for equinus gait in children with cerebral palsy.
    Bennett D, Walsh M, O'Sullivan R, Gallagher J, O'Brien T, Newman CJ.
    J Pediatr Orthop; 2007 Dec; 27(3):288-94. PubMed ID: 17414011
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
    Newman CJ, Kennedy A, Walsh M, O'Brien T, Lynch B, Hensey O.
    J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
    [Abstract] [Full Text] [Related]

  • 16. Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency.
    Molenaers G, Schörkhuber V, Fagard K, Van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Desloovere K.
    Eur J Paediatr Neurol; 2009 Sep; 13(5):421-9. PubMed ID: 18977158
    [Abstract] [Full Text] [Related]

  • 17. Conservative management of dynamic equinus in diplegic children treated by gait improvement surgery.
    Saraph V, Zwick EB, Steinwender C, Steinwender G, Linhart W.
    J Pediatr Orthop B; 2001 Oct; 10(4):287-92. PubMed ID: 11727370
    [Abstract] [Full Text] [Related]

  • 18. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
    Frasson E, Dall'ora E, Bordignon M, Brigo F, Tocco P, Primon D, Didonè G, Vicentini S, Fiaschi A, Bertolasi L.
    J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
    [Abstract] [Full Text] [Related]

  • 19. The association of equinus and primary genu recurvatum gait in cerebral palsy.
    Klotz MC, Wolf SI, Heitzmann D, Maier MW, Braatz F, Dreher T.
    Res Dev Disabil; 2014 Jun; 35(6):1357-63. PubMed ID: 24705489
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI, Wasay M, Awan S.
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.